In patients with NSTE-ACS in whom there are indica- tions for triple therapy, the benefit of such therapy in terms of prevention of stent thrombosis, thromboembolic events, and recurrent MI must be weighed against the risk of bleeding complications. Similarly, DAPT, in addition to anticoagulant Patient/family education Plan of care for AMI 2010 CPG for cardiopulmonary resuscitation and emergency cardiovascular care part 9: postcardiac arrest care31 Recognizing symptoms of MI Activating EMS, signs and symptoms for urgent vs. emergency evaluations CPR training for family members Risk assessment and prognosis Advanced directives Social networks/social isolation Socioeconomic factors Access to health insurance coverage Access to clinicians Effective communication and care coordination513 Disability Cardiovascular disability: updating Social Security listings514 Social services Community services ACE indicates angiotensin-converting enzyme; AF, atrial fibrillation; AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; BP, blood pressure; CCB, calcium channel blocker; CPG, clinical practice guideline; CPR, cardiopulmonary resuscitation; DAPT, dual antiplatelet therapy; DBT, device-based therapy; ECC, emergency cardiovascular care; EMS, emergency medical services; HF, heart failure; MET, metabolic equivalent; MI, myocardial infarction; NSAID, nonsteroidal anti-inflammatory drug; NSTE-ACS, non T-elevation acute coronary syndromes; PCI, percutaneous coronary intervention; PPI, protein pump inhibitor; SIHD, stable ischemic heart disease; and STEMI, ST-elevation myocardial infarction. Table 10. Continued Plan of Care Resources/References Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline e379 therapy, requires consideration of the increased risk of bleed- ing. It is essential that therapeutic decision making in this crit- ical area include discussion with the patient about the options, advantages, and limitations of available approaches. 